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Powered by Gas—A Ligand
for a Fruit Fly Nuclear Receptor
The difficulty in identifying ligands for nuclear hor-
mone receptors remains an obstacle to understand-
ing their function. For example, in the fruit fly Drosoph-
ila melanogaster, only one of its nuclear receptors has
a known ligand. In this issue of Cell, Reinking et al.
(2005) report that the fruit fly E75 nuclear receptor
contains heme in its ligand binding pocket and that
the oxidation state of this molecule controls E75 ac-
tivity. They also show that E75-heme responds to the
small diatomic gases, nitric oxide and carbon monox-
ide. This study sheds light on how heme, gas signal-
ing, and nuclear receptors interact to control meta-
bolic and developmental pathways.
Nuclear receptors are transcription factors that are reg-
ulated by their ligands. They act at the crossroads of
key biological processes including embryonic develop-
ment, maturation, aging, homeostasis, and metabo-
lism. Nuclear receptors are defined by the presence of
two functional domains, a highly conserved DNA bind-
ing domain that targets the receptor to specific re-
sponse elements in the genome, and a ligand binding
domain (LBD) that often interacts with small lipophiliccompounds. Binding of ligand triggers an allosteric
shift in LBD conformation that can lead to changes in
the subcellular localization of nuclear receptors, their
DNA binding affinity, their ability to dimerize, recruit co-
factors, and their transcriptional activity. The ligands
that regulate these nuclear-receptor activities include
well-known hormones such as steroids, retinoic acid,
and thyroid hormone. The realization that nuclear re-
ceptors are highly conserved through evolution has led
to genomic definitions of this family, which includes 48
genes in humans, 284 genes in the nematode Caeno-
rhabditis elegans, and 18 genes in Drosophila (Maglich
et al., 2001). The rapid discovery of these receptors has
paved the way for a new field of “reverse endocrinol-
ogy” where orphan nuclear receptors are used to iden-
tify their cognate ligands and thus define new signaling
pathways. Given the critical role that nuclear receptors
play at the interface between chemical signaling and
transcriptional control, identifying their ligands has be-
come a central focus for the field of nuclear-receptor
research.
During the past few years, crystallographic studies of
nuclear-receptor LBDs have provided a major means
of ligand identification, enabling the detection of small
compounds buried within the lipophilic pocket. These
“fortuitous ligands” copurify with the LBD and provide
critical clues to natural ligands for the corresponding
nuclear receptor. Many such studies have graced the
pages of Cell Press journals. A paper in this issue of
Cell by Reinking et al. (2005), however, reports the dis-
covery of a ligand for the Drosophila E75 nuclear recep-
tor and provides several new twists to the field of re-
verse endocrinology. The first surprise is the elegance
of their discovery, depicted in the first figure of the pa-
per as a photograph of a BioRad Econo-Column with
the bright red E75-LBD purified from bacteria. The star-
tling color led the authors to guess that this nuclear
receptor might bind to a heme molecule (protoporphy-
rin IX bound to iron), a hypothesis they confirmed by
biophysical techniques. They demonstrate a 1:1 stoi-
chiometry for heme binding to E75 and a remarkable
avidity. The investigators were unable to detect E75
protein in the absence of heme, and the levels of stable
E75-LBD varied in parallel with the amount of heme,
suggesting that this compound is required for E75 pro-
tein stability (Figure 1A). In an unprecedented step for
nuclear-receptor ligand identification, the authors ex-
tended their studies to full-length E75 protein purified
from SF9 and S2 insect cell lines as well as from de-
veloping fruit fly pupae. They demonstrated that E75 is
always conjugated with heme in stoichiometric amounts.
Like other heme-containing proteins, the heme group
in E75 can be reversibly oxidized and reduced, leading
the authors to propose that this nuclear receptor might
act as a redox sensor. They show that the ability of E75
to interact with the AF2 domain of its regulatory partner,
the DHR3 orphan nuclear receptor, is dependent upon the
presence of a reduced Fe(II) heme group. This links the
oxidative state of the E75-heme group to its functional
interactions with DHR3 and thus the transcriptional ac-
tivity of the DHR3-E75 complex (Figure 1B).
A key property of heme-containing proteins is their
ability to be regulated by direct binding of the small




















Figure 1. Three Ways to Regulate the Fruit Fly E75 Nuclear Re-
tceptor
L(A) Binding of heme (red cross) stabilizes the E75 nuclear receptor
o(blue oval), resulting in an overall increase in E75 levels.
(B) Possible regulation of DHR3 and its repressive partner E75 v
based on the redox state of the heme group bound to E75. b
(C) Possible regulation of E75 and DHR3 based on binding of E75 t
to the small diatomic gas, NO (yellow star). The red bars and green




b(NO). These gases act as short-lived signaling mole-
tcules that are locally synthesized and diffuse freely be-
ttween cells. Reinking et al. (2005) found that either CO
aor NO can bind to the reduced form of E75 and that
mbinding of CO blocks the ability of E75 to bind to the
fAF2 domain of DHR3. They also show, at least for NO,
hthat the dissociation of DHR3 and E75 has functional
consequences because DHR3 can now revert to being
tan activator in the absence of its E75 repressive partner
a(White et al., 1997; Figure 1C).
iA challenge for the future is to bridge the gap be-
rtween these new biochemical discoveries and the bio-
ilogical functions of E75. Transcription of the E75 gene
nis induced by ecdysteroids, and fly mutants lacking E75
thave reduced ecdysteroid titers. These mutant flies die
wprimarily during larval stages with defects in molting,
tsuggesting that E75 acts in a feed-forward pathway to
control ecdysteroid biosynthesis or release (Bialecki et
Cal., 2002). Interestingly, among its many regulatory
Dfunctions, NO has been implicated in insect steroid bio-
Hsynthesis, acting through its critical downstream effec-
Utor, cGMP (Maniere et al., 2003). Null mutations that af-
Sfect nitric-oxide synthase (NOS), the key enzyme for NO
production, result in early larval lethality, although the
phenotype of these larvae has not been described (Re-
Sgulski et al., 2004). It will be interesting to determine if
NOS mutations are associated with ecdysteroid defici- B
encies and if NOS alleles display genetic interactions T
with E75 mutants. Another possible point where E75 C
and NOS could regulate molting is through ecdysis-trig- 3
gering hormone (ETH), which is a key regulator of larval K
Bmolting behavior that also exerts its effects through
cGMP (Kingan et al., 1997). In addition, studies in the Mobacco hornworm, Manduca sexta, have shown that
cdysteroids can reduce NO levels in neuronal cells
uring metamorphosis, attenuating their inhibition of
euronal cell proliferation (Champlin and Truman,
000). It would be interesting to determine if there are
imilar effects in Drosophila and if E75 mutations im-
act these pathways.
As the authors note, one possible role for heme in
75 signaling emerges from studies in the yellow fever
osquito, Aedes aegypti. A pulse of ecdysteroids in the
emale mosquito, in response to a blood meal, triggers
cascade of gene expression that ultimately controls
ogenesis and yolk production. The E75 gene is one of
he primary ecdysteroid-induced genes in this pathway
Pierceall et al., 1999). Given that heme is a major by-
roduct from the blood meal, this system provides an
deal context for testing the hypothesis that heme
evels, or the state of heme oxidation, might regulate
75 function.
Heme binding by E75 can be disrupted by mutating
he two most highly conserved histidine residues in the
BD, residues that are also present in the vertebrate
rtholog of E75, Rev-Erbα. Rev-Erbα interacts with the
ertebrate ortholog of DHR3, RORα, raising the possi-
ility that studies of these nuclear receptors in one sys-
em will have direct implications for how they operate
n all higher organisms. Both Rev-Erbα and RORα are
ritical components of the mammalian circadian clock,
n elegant molecular circuit in which NO, CO, and heme
re key regulatory molecules (Pardee et al., 2004). It will
e interesting to determine if E75 and DHR3 contribute
o circadian cycling in Drosophila and, if so, whether
his provides a context for studying how heme and di-
tomic gas signaling regulate E75 function. An experi-
ental direction that we can expect to see in the near
uture is to test whether the Rev-Erbα LBD binds to
eme, as predicted.
The Reinking et al. (2005) study adds nuclear recep-
ors to the list of transcription factors that bind to heme
nd depend on this molecule for their regulatory activ-
ty. In addition, this is the first description of a nuclear
eceptor that can act as a redox sensor and participate
n diatomic gas signaling. These discoveries provide a
ew context for thinking about nuclear-receptor regula-
ion and set the stage for studies of E75 and DHR3,
ith direct implications for the regulation of their or-
hologous mammalian receptors.
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